Bioventix Share Discussion Threads

[gsbmba99] 23/5/2024 09:39

“Building on the foundation our team developed last year, Quanterix is entering a new innovation and product delivery phase,” said Masoud Toloue, Chief Executive Officer of Quanterix. “We’ve announced the first of several new assays that could re-define the way Tau is measured from the brain versus peripheral sources. We will continue to lead in bringing novel biomarker detection solutions to market for the research community; developing tests to study and enable the early detection of neuro-pathologies such as Multiple Sclerosis, Parkinson’s, and Alzheimer’s disease.” ( A bit unclear but maybe brain-derived tau?

Page 6 of the accompanying results presentation makes it clear Mr. Toloue is indeed talking about Quanterix introducing an assay for brain-derived tau in Q2 ( Could this be a first commercial success for the UGOT/BVXP BD-tau antibody?

[castleford tiger] 16/4/2024 12:40

interesting company for sure. Enjoyed the bash

[davidosh] 14/4/2024 17:36

It will be interesting show tomorrow evening as Bioventix are going to feature on the Mello BASH (Buy, Avoid, Sell or Hold)

[alter ego] 09/4/2024 23:13

Doctor88, your links don’t work cos advfn change them. If you type capital letters like this hTTp then they are clickable cos advfn don’t alter them.

[doctor888] 09/4/2024 22:32

More data in another premier journal, Neurology. Higher bd-tau levels now also shown to be associated with adverse outcome in ischaemic stroke!

Alzheimer's, stroke, what next?

I hold a 'full' position now in the portfolio - hence shouting from the rooftops!

[doctor888] 05/4/2024 11:09

Great data in one of the premier journals. So we are involved in bd-tau which is superior to the p-tau in the UK studies. Even better.

[doctor888] 04/4/2024 08:52

More trials for blood tests in dementia. Hope our antibodies are being used here!

[alter ego] 26/3/2024 09:53

Thx. Should have paid more attention in Maths at school :)

[stepone68] 26/3/2024 09:48

Looks like R-squared, so it's just an indication of how well the straight line fits the underlying data. Shame it wasn't a bit more exponential-ish.

[alter ego] 25/3/2024 23:00

?=9315. What value is ? Please

[janeann] 25/3/2024 10:50

Yes .... thats a hell of a price jump as well. Pity the troponon sales fell a little short. Added a few this morn.

[melody9999] 25/3/2024 10:39

I see Cavendish have raised their price target to 5900p from 4400p in Oct 23. Will be happy to see the BVXP once again climb above the Cavendish target price!

[c3479z] 25/3/2024 07:32

steady, points to competitive Alzheimer's environment with in-house mabs being developed by some IVD companies and alternative competition - market ought to be sufficiently large to support multiple competitors, temporary slowdown in troponin rate of adoption.

[suetballs] 13/3/2024 08:36

Half year results due later this month.
I expect another steady as she goes performance.
Suet

[maddox] 01/3/2024 10:30

Hahaha, Blackhorse looking to invest his 'profits' from his investment in Watkins Jones WJG, I assume. Of course if he had been invested here - there would have been daily one line posts.

[alter ego] 21/2/2024 15:36

the filtered ebonised equine makes an unwelcome appearance. No doubt spots an opportunity to talk its own book as ever.

[blackhorse23] 21/2/2024 14:28

Money moving to APH [LSE] , excellent growing health care company

[suetballs] 21/2/2024 10:49

Yes one heck of a rise since October last year.
Suet

[stepone68] 21/2/2024 10:34

Share price starting with a '5' now. Certainly feels like it is popular at the moment.

[suetballs] 16/2/2024 16:07

Something afoot?
Suet

[janeann] 16/2/2024 15:22

maddox - all I can say is I can sell a shed load of these at 49.10 at present. someone still wants them

49.15 now!!

[maddox] 16/2/2024 11:31

So, we're hitting new All Time High's despite the Director sale; 4848p as I post. Anyone with Level 2 able to shed some light on the activity?

[janeann] 12/2/2024 15:36

Maddox... agree completey.... this has had plenty of strenght since Harrisons sale a could of weeks back. someone still wants them at 47.01!

[maddox] 12/2/2024 12:37

BVXP are in the running to develop what has been described as the 'Holy Grail' of diagnostic testing - an early stage Alzheimer's test.

BBC Radio 4 Today report on new Alzheimer's treatments. Mentions that there are about 28 dementia drugs in late stage development. Whilst the current two leading drugs show efficacy the promise is of better drugs being developed.

The need for an early stage diagnostic test is clear in this report. Arguably, it's equally as important to have a simple early stage test as the drugs.